[HTML][HTML] CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells

R Majeti, MP Chao, AA Alizadeh, WW Pang, S Jaiswal… - Cell, 2009 - cell.com
Acute myeloid leukemia (AML) is organized as a cellular hierarchy initiated and maintained
by a subset of self-renewing leukemia stem cells (LSC). We hypothesized that increased …

[HTML][HTML] A phase I study of CC-90002, a monoclonal antibody targeting CD47, in patients with relapsed and/or refractory (R/R) acute myeloid leukemia (AML) and high …

AM Zeidan, DJ DeAngelo, JM Palmer, CS Seet… - Blood, 2019 - Elsevier
Background: CD47 is a transmembrane protein ubiquitously expressed in human cells.
CD47 is overexpressed in various malignancies and is correlated with negative prognosis in …

Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia

MP Chao, AA Alizadeh, C Tang, M Jan… - Cancer research, 2011 - AACR
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and
constitutes 15% of adult leukemias. Although overall prognosis for pediatric ALL is …

Role of CD47 in hematological malignancies

E Eladl, R Tremblay-LeMay, N Rastgoo… - Journal of hematology & …, 2020 - Springer
CD47, or integrin-associated protein, is a cell surface ligand expressed in low levels by
nearly all cells of the body. It plays an integral role in various immune responses as well as …

Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential

J Liu, L Wang, F Zhao, S Tseng, C Narayanan, L Shura… - PloS one, 2015 - journals.plos.org
CD47 is a widely expressed cell surface protein that functions as a regulator of phagocytosis
mediated by cells of the innate immune system, such as macrophages and dendritic cells …

CD47: a cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease

PA Oldenborg - International Scholarly Research Notices, 2013 - Wiley Online Library
Interactions between cells and their surroundings are important for proper function and
homeostasis in a multicellular organism. These interactions can either be established …

Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies

EC Pietsch, J Dong, R Cardoso, X Zhang, D Chin… - Blood cancer …, 2017 - nature.com
CD47, a broadly expressed cell surface protein, inhibits cell phagocytosis via interaction
with phagocyte-expressed SIRPα. A variety of hematological malignancies demonstrate …

The Macrophage 'Do not eat me'signal, CD47, is a clinically validated cancer immunotherapy target

CH Takimoto, MP Chao, C Gibbs… - Annals of …, 2019 - annalsofoncology.org
CD47 is a potent 'do not eat me'signal that enables cancer cells to evade detection by the
innate immune system, thereby avoiding destruction by first responder cells, such as …

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

S Jaiswal, CHM Jamieson, WW Pang, CY Park… - Cell, 2009 - cell.com
Macrophages clear pathogens and damaged or aged cells from the blood stream via
phagocytosis. Cell-surface CD47 interacts with its receptor on macrophages, SIRPα, to …

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia

C Riether, CM Schürch, ED Bührer… - Journal of Experimental …, 2017 - rupress.org
Aberrant proliferation, symmetric self-renewal, increased survival, and defective
differentiation of malignant blasts are key oncogenic drivers in acute myeloid leukemia …